Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

November 01, 1994; Volume 46,Issue 5
  • You have access
    Nucleotide-independent modulation of Ca(2+)-dependent K+ channel current by a mu-type opioid receptor.
    W A Twitchell and S G Rane
    Molecular Pharmacology November 1994, 46 (5) 793-798;
  • You have access
    Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands.
    E L Barker, H L Kimmel and R D Blakely
    Molecular Pharmacology November 1994, 46 (5) 799-807;
  • You have access
    Functional reconstitution of platelet thromboxane A2 receptors with Gq and Gi2 in phospholipid vesicles.
    F Ushikubi, K Nakamura and S Narumiya
    Molecular Pharmacology November 1994, 46 (5) 808-816;
  • You have access
    Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes.
    H Nonaka, A Mori, M Ichimura, T Shindou, K Yanagawa, J Shimada and H Kase
    Molecular Pharmacology November 1994, 46 (5) 817-822;
  • You have access
    Cloning, expression, and tissue distribution of the rat homolog of the bovine alpha 1C-adrenergic receptor provide evidence for its classification as the alpha 1A subtype.
    D M Perez, M T Piascik, N Malik, R Gaivin and R M Graham
    Molecular Pharmacology November 1994, 46 (5) 823-831;
  • You have access
    Coupling of the C5a receptor to Gi in U-937 cells and in cells transfected with C5a receptor cDNA.
    M Vanek, L D Hawkins and F Gusovsky
    Molecular Pharmacology November 1994, 46 (5) 832-839;
  • You have access
    Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
    Z Szallasi, M F Denning, C B Smith, A A Dlugosz, S H Yuspa, G R Pettit and P M Blumberg
    Molecular Pharmacology November 1994, 46 (5) 840-850;
  • You have access
    Potentiation of gamma-aminobutyric acid type A receptor-mediated chloride currents by novel halogenated compounds correlates with their abilities to induce general anesthesia.
    S J Mihic, S J McQuilkin, E I Eger, P Ionescu and R A Harris
    Molecular Pharmacology November 1994, 46 (5) 851-857;
  • You have access
    Site-directed mutagenesis of N-linked glycosylation sites on the gamma-aminobutyric acid type A receptor alpha 1 subunit.
    A L Buller, G A Hastings, E F Kirkness and C M Fraser
    Molecular Pharmacology November 1994, 46 (5) 858-865;
  • You have access
    Interaction of an estramustine photoaffinity analogue with cytoskeletal proteins in prostate carcinoma cells.
    L A Speicher, N Laing, L R Barone, J D Robbins, K B Seamon and K D Tew
    Molecular Pharmacology November 1994, 46 (5) 866-872;
  • You have access
    Ethanol-responsive genes in neural cells include the 78-kilodalton glucose-regulated protein (GRP78) and 94-kilodalton glucose-regulated protein (GRP94) molecular chaperones.
    M F Miles, N Wilke, M Elliot, W Tanner and S Shah
    Molecular Pharmacology November 1994, 46 (5) 873-879;
  • You have access
    Transcriptional regulation of secretogranin II and chromogranin B by cyclic AMP in a rat pheochromocytoma cell line.
    M E Thompson, D L Valentine, S J Strada, J A Wagner and J G Scammell
    Molecular Pharmacology November 1994, 46 (5) 880-889;
  • You have access
    Programmed cell death (apoptosis) of mouse fibroblasts is induced by the topoisomerase II inhibitor etoposide.
    K Mizumoto, R J Rothman and J L Farber
    Molecular Pharmacology November 1994, 46 (5) 890-895;
  • You have access
    The daunorubicin-binding protein of Mr 54,000 is an aldehyde dehydrogenase and is down-regulated in mouse liver tumors and in tumor cell lines.
    P Banfi, C Lanzi, F S Falvella, M Gariboldi, R A Gambetta and T A Dragani
    Molecular Pharmacology November 1994, 46 (5) 896-900;
  • You have access
    Doxorubicin-induced DNA degradation in murine thymocytes.
    G Zaleskis, E Berleth, S Verstovsek, M J Ehrke and E Mihich
    Molecular Pharmacology November 1994, 46 (5) 901-908;
  • You have access
    Transcriptional up-regulation of gamma-glutamylcysteine synthetase gene expression in melphalan-resistant human prostate carcinoma cells.
    R T Mulcahy, S Untawale and J J Gipp
    Molecular Pharmacology November 1994, 46 (5) 909-914;
  • You have access
    Analysis of the four alleles of the murine aryl hydrocarbon receptor.
    A Poland, D Palen and E Glover
    Molecular Pharmacology November 1994, 46 (5) 915-921;
  • You have access
    Functional cytochrome P4503A isoforms in human embryonic tissues: expression during organogenesis.
    H Y Yang, Q P Lee, A E Rettie and M R Juchau
    Molecular Pharmacology November 1994, 46 (5) 922-928;
  • You have access
    Selectivity of agonists for cloned alpha 1-adrenergic receptor subtypes.
    K P Minneman, T L Theroux, S Hollinger, C Han and T A Esbenshade
    Molecular Pharmacology November 1994, 46 (5) 929-936;
  • You have access
    Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonists and inverse agonists.
    R S Westphal and E Sanders-Bush
    Molecular Pharmacology November 1994, 46 (5) 937-942;
  • You have access
    Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.
    S Patel, A J Smith, K L Chapman, A E Fletcher, J A Kemp, G R Marshall, R J Hargreaves, W Ryecroft, L L Iversen and S D Iversen
    Molecular Pharmacology November 1994, 46 (5) 943-948;
  • You have access
    Discrimination between putative bradykinin B2 receptor subtypes in guinea pig ileum smooth muscle membranes with a selective, iodinatable, bradykinin analogue.
    C Liebmann, R Bossé and E Escher
    Molecular Pharmacology November 1994, 46 (5) 949-956;
  • You have access
    Molecular pharmacology of gamma-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different alpha, beta, and gamma receptor subunit combinations.
    B Ebert, K A Wafford, P J Whiting, P Krogsgaard-Larsen and J A Kemp
    Molecular Pharmacology November 1994, 46 (5) 957-963;
  • You have access
    Amino- and carboxyl-terminal domains specify the identity of the delta subunit in assembly of the mouse muscle nicotinic acetylcholine receptor.
    X M Yu and Z W Hall
    Molecular Pharmacology November 1994, 46 (5) 964-969;
  • You have access
    Block of the inactivating potassium channel by clofilium and hydroxylamine depends on the sequence of the pore region.
    A J Yool
    Molecular Pharmacology November 1994, 46 (5) 970-976;
  • You have access
    Correlation of neuroactive steroid modulation of [35S]t-butylbicyclophosphorothionate and [3H]flunitrazepam binding and gamma-aminobutyric acidA receptor function.
    J E Hawkinson, C L Kimbrough, D Belelli, J J Lambert, R H Purdy and N C Lan
    Molecular Pharmacology November 1994, 46 (5) 977-985;
  • You have access
    Glutamate uptake is inhibited by arachidonic acid and oxygen radicals via two distinct and additive mechanisms.
    A Volterra, D Trotti and G Racagni
    Molecular Pharmacology November 1994, 46 (5) 986-992;
  • You have access
    Functional heterogeneity of nicotinic receptors in the avian lateral spiriform nucleus detected with trimethaphan.
    W R Weaver, K M Wolf and V A Chiappinelli
    Molecular Pharmacology November 1994, 46 (5) 993-1001;
  • You have access
    Enhancement by 2'-deoxycoformycin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of 2',3'-dideoxyadenosine and 2'-beta-fluoro-2',3'-dideoxyadenosine.
    G S Ahluwalia, D A Cooney, T Shirasaka, H Mitsuya, J S Driscoll and D G Johns
    Molecular Pharmacology November 1994, 46 (5) 1002-1008;
  • You have access
    New aspects of the kinetics of inhibition by lincomycin of peptide bond formation.
    S Kallia-Raftopoulos, D L Kalpaxis and C Coutsogeorgopoulos
    Molecular Pharmacology November 1994, 46 (5) 1009-1014;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 46, Issue 5
1 Nov 1994
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics